Skip to main content

Table 2 Systematic and ocular adverse events

From: Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study

  Sirolimus Anti-VEGF
Systemic events   
 Serious adverse events 3a 1b
 Minor adverse events 3 8
Ocular events   
 Serious adverse events 3 0
 Minor adverse events 7 7
  1. This table lists the number of adverse events in each group, separated into systematic and ocular adverse events
  2. aTwo deaths due to pneumonia and pulmonary embolism, and one hospitalization due to a myocardial infection
  3. bHospitalization due to pulmonary embolism